Research team to study role of CMV persistence in the lung and its effect on the pulmonary virome, as well as translate findings to treatments.Continue reading
Author Archive: AZBio
NATIONAL CAMPAIGN LAUNCHED TO HELP INCREASE DIVERSITY IN CLINICAL TRIALS
I’m In campaign to educate underrepresented populations about clinical trial participationContinue reading
Study Led by UA’s Dr. C. Kent Kwoh Finds Glucosamine Fails to Prevent Deterioration of Knee Cartilage, Decrease Pain
Findings indicate that glucosamine does not decrease pain or improve knee bone marrow lesions—thought to be a source of pain in those with osteoarthritis affecting 27 million Americans over age 25Continue reading
BIO Applauds CMS for Withdrawing Problematic Part D Proposals
March 10, 2014 – Washington DC – The Biotechnology Industry Organization (BIO) commended the Centers for Medicare & Medicaid Services (CMS) for announcing their decision to halt movement on several proposals in their Medicare Part D draft rule, including the agency’s proposal to eliminate protected class status for certain drug classes, as well as other proposals such as those related to reducing the number of Part D plans a particular plan sponsor may offer, and the proposal to clarify the non-interference provisions.Continue reading
Ventana and Bayer Extend Collaboration
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into a multi-year agreement with Bayer Pharma AG (Bayer) to develop companion diagnostics, with a focus on immunohistochemistry (IHC), across Bayer’s portfolio of targeted therapy projects. This new agreement extends an already existing collaboration and focuses on the development of diagnostic tests for Bayer’s biomarker targeted therapeutics from early discovery through commercialization.Continue reading
UA Study of HIV-Related Lung Diseases to Help Understanding of Pulmonary Immunity and Vaccine Responses
Dr. Kenneth S. Knox and his UA College of Medicine – Tucson research team aim to understand the causes of HIV-associated chronic obstructive pulmonary disease (COPD), pulmonary hypertension and immune reconstitution inflammatory syndrome (IRIS), funded by a grant from the National Heart, Lung, and Blood Institute.Continue reading
Algae Anyone? NAU, UA and ASU Team up on Algae Research
Arizona State University, Northern Arizona University and University of Arizona Partner on Algae Project to Produce Valuable Products and Remediate WastewaterContinue reading
BIO weighs in on the Presidential Budget
Washington, DC (March 5, 2014) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Obama’s FY 2015 budget proposal:Continue reading
Dr. Daniel D. Von Hoff named one of ASCO’s 50 Oncology Luminaries
TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is named one of ASCO’s 50 Oncology Luminaries. Dr. Von Hoff’s research led to development of numerous therapeutic agents, and improved patient care.Continue reading
International Panel of Pathology Leaders Develop Principles for Patient Safety
An international panel of leaders in the pathology community today announced its support of four principles designed to drive positive change and improve patient safety in the anatomic pathology laboratory. The “Principles for Pathology and Patient Safety” address key issues where the expressed need for standardization and solutions is most acute.Continue reading